Nelson Peltz May or May Not Have a Board Seat at P&G, but His Influence Is Already Evident
Yesterday, Procter & Gamble (NYSE: PG) revealed that activist investor Nelson Peltz has jumped ahead in a proxy vote recount to determine whether his firm Trian Partners can obtain a seat on P&G's board. Shareholders may remember that P&G rushed to declare victory in mid-October based on initial estimates, before independent proxy-vote tabulator IVS Associates had processed all the votes.
In what is decidedly not the final round of this proxy war -- in which the two sides have collectively spent over $125 million -- Peltz now leads the vote count by a margin which, if it gets any slimmer, will soon be reported in scientific notation: 0.0016%.
Image source: Getty Images.
Source: Fool.com
Procter & Gamble Co. Aktie
152,92 €
-0,10 %
Volle Unterstützung für Procter & Gamble Co.: Nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Das Community-Kursziel von 159 € für Procter & Gamble Co. deutet auf ein leicht positives Wachstumspotenzial gegenüber 152.92 € hin.
